Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Degree

Medical Specialty

Submit

Expanding the Spectrum of HER2 Positivity for Precision Breast Cancer Care: Clinical Implications of HER2-Low Status

Source: Expanding the Spectrum of HER2 Positivity for Breast Cancer Care: Implications of HER2-Low Status

In this on-demand webcast from a live symposium, Nadia Harbeck, MD, PhD; Komal Jhaveri, MD; and Heather McArthur, MD, MPH, discuss current guidelines for the assessment of HER2 status in advanced breast cancer, including expanding the spectrum of HER2 positivity and mastering the use and safety of novel antibody–drug conjugates.

Nadia Harbeck, MD, PhD

Komal Jhaveri, MD

Heather McArthur, MD, MPH

Released: January 19, 2023 Expiration: No longer available for credit

Welcome to the CCO Site

Expanding the Spectrum of HER2 Positivity for Precision Breast Cancer Care: Clinical Implications of HER2-Low Status

Leaving the CCO site